Search

everythinglearnresearchcommunity

for

Search:↓

Two specific hair keratin genes are active during hair growth and decline as hair transitions to rest.

Higher levels of IL-1R1 and hsa-miR-19b-3p may help diagnose and predict alopecia areata severity.

ETS2 is crucial in squamous cell carcinoma development and could be a therapeutic target.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

K6/ODC transgenic mice are effective for quickly identifying cancer-causing chemicals.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

Tissue-specific variation in mutant load complicates genetic counseling and prenatal diagnosis.

A specific gene variant (rs4833095) is linked to a higher risk of alopecia areata in Koreans.

VEGF and VEGFR-2 genes influence feather maturity, and specific genetic markers can improve chicken breeding.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

Ber‐EP4 marks cells related to the secondary hair germ in hair follicles.

A specific group of skin stem cells was found to help maintain hair follicle cells.

Certain genes may be linked to autoimmune conditions in people with alopecia areata.

AMH is a promising biomarker for diagnosing PCOS.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

CD34 marks potential stem cells in dog hair follicles.

The scant hair in snthr-1Bao mice is likely caused by a deletion affecting the Plcd1 gene.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

The new method found new shared genetic areas linked to both Type 2 Diabetes and Prostate Cancer.

The Fas/FasL pathway may play a role in alopecia areata.

Trichilemmoma, BCC, and SCC tumors have different stem cell marker expressions.

Variants in the CCDC47 gene are linked to trichohepatoneurodevelopmental syndrome.

New imaging technology can show up to 40 different markers in hair loss tissue, helping to understand hair disease better.

Stem cells are in deep skin layers, while differentiating cells are in shallow layers.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Certain DNA variants can predict straight hair in Europeans but are not highly specific.